Related Experiment Videos
[Application of NMR-CT for malignant bone tumors]
Kaku Igaku. the Japanese Journal of Nuclear Medicine
|December 1, 1984
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Adjuvant therapy in pStage IA1-IIA lung adenocarcinoma (pN0): A multicenter study focusing on EGFR mutations and recurrence patterns (CReGYT-01 EGFR study).
Lung cancer (Amsterdam, Netherlands)·2025
Five-year point prevalence survey of healthcare-associated infections and antimicrobial use in a Japanese university hospital.
Infection prevention in practice·2021
The Japan-Multimodal Intervention Trial for Prevention of Dementia (J-MINT): The Study Protocol for an 18-Month, Multicenter, Randomized, Controlled Trial.
The journal of prevention of Alzheimer's disease·2021
[Prevention of Radiation Detection Issues at International Airports Following Nuclear Medicine Procedures: The Role of Pre-travel Screening].
Kaku igaku. The Japanese journal of nuclear medicine·2026
[Prognostic Value of Myocardial Flow Reserve Derived from 13N-ammonia PET in Patients with Ischemic Heart Disease in Japan].
Kaku igaku. The Japanese journal of nuclear medicine·2026
[The 47th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 50th Survey in 2024)].
Kaku igaku. The Japanese journal of nuclear medicine·2026
[A Report on Health Resource Use in Internal Radiation Therapy Using Lutetium-177 (177Lu)-PSMA-617].
Kaku igaku. The Japanese journal of nuclear medicine·2025
[Evaluation of Appropriate Treatment Infrastructure for Radionuclide Therapy Through Discrete Event Simulation].
Kaku igaku. The Japanese journal of nuclear medicine·2025
Treatment Initiation of Definitive Radiotherapy in Patients With Locally Advanced Head and Neck Cancer.
Cancer control : journal of the Moffitt Cancer Center·2026
Octreotide as Adjunctive Therapy for Catecholamine-Secreting Pheochromocytoma and Paraganglioma.
The Journal of clinical endocrinology and metabolism·2026
Zanubrutinib versus fludarabine, cyclophosphamide and rituximab in fit, treatment-naïve patients with chronic lymphocytic leukemia: a matching-adjusted indirect comparison.
Journal of comparative effectiveness research·2026